In the complex and fast-moving Precision Medicines market clients seek advisors who can provide deep scientific, technical and business insights at a local and global level. Part of the Healthcare and Life Sciences Strategy team, our Precision Medicine practice is a leader in this innovative area of medicine across all therapeutic areas, in markets around the world, with all relevant stakeholders and fueled by experience across the value chain.
The real keys to innovative deal making in Precision Medicine in 2022
Industry leaders Kristin Pothier, KPMG Global Deal Advisory and Strategy Leader for Healthcare and Life Sciences, and Bonnie Anderson, Chairwoman and former CEO of Veracyte, talk about how strategic deals transformed the company and enabled its growth to market leadership. Kristin and Bonnie discuss the end-to-end journey for successful transactions - from strategic planning, through due diligence, integration, and transformation – and offer outlooks for the year ahead.
See us in action
Watch our Precision Medicine leaders talk about the practice and how KPMG is supporting our clients in their deals, and shaping their strategic direction and operations within this innovative industry.